Gennex Laboratories
10.30
-0.06(-0.58%)
Market Cap₹250.24 Cr
PE Ratio12.79
IndustryHealthcare
Company Performance:
1D-0.58%
1M+18.80%
6M-29.50%
1Y-25.47%
5Y+41.68%
View Company Insightsright
More news about Gennex Laboratories
14Feb 26
Gennex Laboratories Independent Director Ms. Shilpa Bung Resigns Due to New Leadership Role
Ms. Shilpa Bung has resigned as Non-Executive Independent Women Director of Gennex Laboratories effective February 14, 2026, citing her new role as Chairperson of CS Hyderabad Chapter. The Board accepted her resignation in their meeting held on the same date. She confirmed no other material reasons exist for her departure and requested relief from all Board Committee memberships. Ms. Bung also serves as independent director in Sigachi Laboratories Limited and Godavari Drugs Limited.
 no imag found
14Aug 25
Gennex Laboratories Reports Robust Q1 Performance with 20% Revenue Growth
Gennex Laboratories Limited announced its Q1 financial results, showing significant growth. Standalone revenue increased by 20.2% to Rs 2,564.00 lacs. Standalone net profit slightly decreased by 0.4% to Rs 414.95 lacs. Consolidated revenue grew by 20.7% to Rs 3,417.75 lacs, while consolidated net profit rose by 7.7% to Rs 501.64 lacs. The company's standalone EPS remained stable at Rs 0.18, while consolidated EPS improved to Rs 0.22. Paid-up equity share capital increased to Rs 2,314.48 lacs.
 no imag found
Gennex Laboratories
10.30
-0.06
(-0.58%)
1 Year Returns:-25.47%
Industry Peers
Sun Pharmaceutical
1,733.50
(+6.98%)
Divis Laboratories
6,477.00
(+1.82%)
Torrent Pharmaceuticals
4,219.80
(+2.49%)
Dr Reddys Laboratories
1,334.50
(+1.32%)
Cipla
1,317.20
(+1.71%)
Lupin
2,324.50
(+1.24%)
Zydus Life Science
939.65
(+1.32%)
Mankind Pharma
2,268.70
(+0.06%)
Aurobindo Pharma
1,416.70
(+0.21%)
Glenmark Pharmaceuticals
2,325.10
(+1.11%)